Oncolys BioPharma Inc. (TYO:4588)

Japan · Delayed Price · Currency is JPY

2,938.00

+78.00 (2.73%)

Apr 20, 2026, 3:19 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2011
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '11 Dec 31, 2011
Drug Discovery Business	31.38M	63.04M	976.18M	642.49M	-
Drug Discovery Business Growth	-50.21%	-93.54%	51.94%	-	-
Pharmaceutical Products	-	-	-	-	313.57M
Pharmaceutical Products Growth	-	-	-	-	-75.74%
Diagnostic Business	-	-	-	-	610.00K
Diagnostic Business Growth	-	-	-	-	-94.69%
Total	31.38M	63.04M	976.18M	642.49M	314.18M
Total Growth	-50.21%	-93.54%	51.94%	104.50%	-75.90%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2011
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '11 Dec 31, 2011
United States of America	31.38M	28.04M	25.79M	35.93M	84.44M
United States of America Growth	11.93%	8.72%	-28.23%	-57.45%	1784.40%
Japan	-	35.00M	950.39M	318.91M	138.91M
Japan Growth	-	-96.32%	198.01%	129.59%	-88.19%
Other Asia	-	-	-	287.65M	90.83M
Other Asia Growth	-	-	-	216.69%	-26.52%
Total	31.38M	63.04M	976.18M	642.49M	314.18M
Total Growth	-50.21%	-93.54%	51.94%	104.50%	-75.90%

Source: S&P Global Market Intelligence.